CAJ | 학술논문

目的：观察康复新液对白血病儿童化疗性口腔溃疡的临床疗效。方法将符合标准的白血病化疗性口腔溃疡患儿随机分为康复新液组25例和思密达组25例,比较两组的溃疡愈合疗效。结果康复新液组有效例数为21例,占84%；无效1例,占16%。思密达组有效24例,占96%；无效1例,占96%。两组疗效比较差异有统计学意义(P<0．05)。康复新液组患儿口腔溃疡的平均消退时间为(7．3±3．2)d,思密达组为(4．1±1．8)d,两组比较差异有统计学意义(P<0．05)。两组均无明显不良反应。结论思密达治疗白血病儿童化疗性口腔溃疡的效果明显优于康复新液,更值得推广使用。
목적：관찰강복신액대백혈병인동화료성구강궤양적림상료효。방법장부합표준적백혈병화료성구강궤양환인수궤분위강복신액조25례화사밀체조25례,비교량조적궤양유합료효。결과강복신액조유효례수위21례,점84%；무효1례,점16%。사밀체조유효24례,점96%；무효1례,점96%。량조료효비교차이유통계학의의(P<0．05)。강복신액조환인구강궤양적평균소퇴시간위(7．3±3．2)d,사밀체조위(4．1±1．8)d,량조비교차이유통계학의의(P<0．05)。량조균무명현불량반응。결론사밀체치료백혈병인동화료성구강궤양적효과명현우우강복신액,경치득추엄사용。
Objective To discusse the clinical efficacy of kangfuxin solution and smecta on oral ulcer of chil-dren with leukemia induced by chemotherapy. Methods Patients who were in line with the standard of oral ulcer were divided into kangfuxin solution group ( 25 cases ) and smecta group ( 25 cases ) , curative efficacy of the two groups were compared. Results The total effective rate of kangfuxin solution group was 84%(21 cases),which was 96%(24 cases) of smecta group,there was significant difference between the two groups(P <0. 05). The average extinction time of kangfuxin solution group was (7. 3 ± 3. 2) d,which was (4. 1 ± 1. 8) d of smecta group,there was significant difference between the two groups( P<0. 05 ) . There was no significant adverse reactions in the two groups. Conclu-sion Efficacy of smecta is more significant than kangfuxin solution in the treatment of oral ulcer induced by chemo-therapy,it is wothy of wide application.